• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Neurology  • Cerebrovascular Disease  • Stroke  • Cardiovascular System  • Surgery  • Surgery, Other  • Drug Therapy  • Drug Therapy, Other  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

Equivalence of Anticoagulation and Antiplatelet Agents

C. Clay Cothren, MD; Walter L. Biffl, MD; Ernest E. Moore, MD; Jeffry L. Kashuk, MD; Jeffrey L. Johnson, MD

Arch Surg. 2009;144(7):685-690.

Hypothesis  We hypothesize that the 2 antithrombotic treatment regimens, systemic heparin sodium vs antiplatelet agents, are equivalent for the treatment of blunt cerebrovascular injuries (BCVIs) to prevent devastating injury-related strokes.

Design  Retrospective review of a prospective database.

Setting  Level I trauma center.

Patients  Patients with BCVIs from January 1, 1997, to January 1, 2007.

Main Outcome Measures  Incidence of cerebrovascular accident (CVA), stratified by treatment.

Results  During the study period, 422 BCVIs were identified in 301 patients (64.8% men; mean [SEM] age, 37.0 [0.8] years; mean [SEM] injury severity score, 27.0 [0.9]). A total of 22 patients presented with neurologic ischemia, and 5 patients sustained CVAs after embolization and/or stenting of an injury. Treatment was initiated for 282 asymptomatic BCVIs (heparin, 192; aspirin, 67; aspirin and/or clopidogrel, 23); 1 patient had a CVA (0.5%). Of 107 patients with untreated, asymptomatic BCVIs, 23 (21.5%) had a CVA. For untreated patients sustaining BCVI-related CVAs, the mean (SEM) time to diagnosis was 58 (10) hours. For those who did not exhibit symptoms within 2 hours of injury, mean time to diagnosis of CVA was 75 (11) hours. Injury healing rates (heparin, 39%; aspirin, 43%; aspirin/clopidogrel, 46%) and injury progression rates (12%; 10%; 15%) were equivalent between therapeutic regimens.

Conclusions  With an overall CVA risk of 21% and a documented latent period, comprehensive screening, early diagnosis, and institution of antithrombotic therapy for BCVI are clearly warranted. The type of treatment, heparin vs antiplatelet agents, does not appear to affect either stroke risk or injury healing rates.

Author Affiliations: Department of Surgery, Denver Health Medical Center and University of Colorado School of Medicine, Denver.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CT Angiography in Head and Neck Trauma
Turkbey et al.
Radiology 2010;255:1008-1009.
FULL TEXT